Pfizer CEO pushes back against Trump claim on vaccine timing
The head of Pfizer, one of the drugmakers racing to develop a coronavirus vaccine, told employees on Thursday he was disappointed that its work was politicized during the presidential debate and tried to reassure U.S. staff that the company won’t bend to pressure to move more quickly.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login